(Circulation. 2000;101:e120.)
© 2000 American Heart Association, Inc.
Circulation Electronic Pages |
Hypertension Center Department of Internal Medicine, Cornell University Medical College/The New York Presbyterian Hospital, New York, NY
Laboratory of Clinical Chemistry National Cardiovascular Center, Osaka, Japan
Research Institute National Cardiovascular Center, Osaka, Japan
| Introduction |
|---|
We have read the article by Kiechl et al1 demonstrating that acquired activated protein C resistance (APC) may be a risk factor for atherosclerosis and arterial thrombosis in whites. We2 previously demonstrated that acquired APC resistance is associated not only with venous thrombosis (deep vein thrombosis and pulmonary thromboembolism) but also with arterial thrombotic disease (cerebral infarction and coronary artery disease) in the Japanese population. It is well known that no Japanese has factor V Leiden mutation because of the founder effect of this mutation.3 Thus, it is likely that in Japanese, some environmental factors might contribute to APC resistance. In addition, we demonstrated a positive association of APC sensitivity ratio with plasma levels of the activated form of factor VII (FVIIa, an activation marker of the early phase of the tissue factor pathway of coagulation4 in healthy subjects; correlation coefficient -0.38, P<0.05, n=33).2 This association was also found in subjects with a predisposing condition of thrombosis, namely, protein C deficiency (correlation coefficient -0.40, P<0.005, n=53). More recently, pregnancy-related APC resistance has also been reported5 to be associated with thrombin-antithrombin complex (an indicator of in vivo thrombin generation) (correlation coefficient with APC sensitivity ratio -0.274, P=0.01, n=128). Thus, the APC resistance may reflect the global insensitivity of APC and may provide a good method to assess the hypercoagulable state in vivo. The hypercoagulable state induced by acquired APC resistance should be given greater emphasis in clinical practice in the future.
| References |
|---|
2. Sakata T, Kario K, Katayama Y, Matsuyama T, Kato H, Miyata T. Clinical significance of activated protein C resistance as a potential marker for hypercoagulable state. Thromb Res. 1996;82:235244.[Medline] [Order article via Infotrieve]
3. Fujimura H, Kambayashi J, Monden M, Kato H, Miyata T. Coagulation factor V Leiden mutation may have a racial background. Thromb Haemost. 1995;74:13811382.[Medline] [Order article via Infotrieve]
4. Kario K, Sakata T, Matsuo T, Miyata T. Factor VII in non-insulin-dependent diabetic patients with microalbuminuria. Lancet. 1993;342:1552. Letter.[Medline] [Order article via Infotrieve]
5. Clark P, Walker ID, Greer I. Acquired activated protein-C resistance in pregnancy and association with increased thrombin generation and fetal weight. Lancet. 1999;353:292293.
Department of Neurology, University Clinic Innsbruck, Innsbruck, Austria
| Introduction |
|---|
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |